Chiesi Farmaceutici S.p.A.
The IN-SIlico molecular DEsign Laboratory (INSIDEL@b) of CNR-IC has established a partnership with Chiesi
Farmaceutici S.p.A. to co-found a Ph.D. fellowship under the program “Dottorato Industriale CNR XXXVI
ciclo” for the application of artificial intelligence in drug discovery and development.
AMBITI DI RICERCA
KEYWORDS
Riferimento
